KQED Radio Staff
Amy Standen is a science reporter for KQED whose work also appears on Morning Edition, All Things Considered, Marketplace and other shows. She was a 2013-14 Rosalynn Carter Fellow for Mental Health Reporting and lives in San Francisco with her family.Her email is email@example.com and you can follow her on Twitter at @amystanden.
Stories (250 archives)
At Stanford's Center for Sleep Sciences and Medicine, there's an unusual group of patients who suffer from narcolepsy who are helping doctors and researchers. They're chihuahuas, poodles and other dogs with a genetic predisposition to the sleep disorder. KQED Science reporter Amy Standen joins us to explain.
A new UC Berkeley research facility is devoted to finding cures for genetic diseases like cancer and cystic fibrosis. The Innovative Genomics Initiative will have a $20 million annual budget, and will use a technology called CRISPR: a fast and precise way to make changes, or fixes, inside the DNA of a cell.
Schizophrenia causes millions of Americans to hallucinate, hearing voices that seem to come from nowhere. Since the 1950s, doctors have prescribed strong anti-psychotic drugs to quell those voices. But one local researcher suggests a controversial new theory, drawing from other cultures. The theory says that in some cases, those voices may be helpful.
Walk through the streets of almost any big city in California, and you're likely to encounter homeless people suffering from schizophrenia. The symptoms -- disturbing hallucinations and delusions -- are frightening and obvious. And yet we know almost nothing about the biology of schizophrenia. There's no blood test for it, and no scan that can diagnose it. In the second of a three-part series on schizophrenia, we meet scientists who are redefining the disease and proposing new treatments.
Scientists recently announced they've discovered new genetic markers for schizophrenia, an often-devastating mental illness that blurs the lines between fantasy and reality. Schizophrenia is also expensive, costing more than $62 billion a year to care for the small number of Americans who are diagnosed with it. In the first of a three-part series, we look at a controversial new approach in California that aims to prevent schizophrenia before it starts.